Geneva, June 22 -- International Clinical Trials Registry received information related to the study (KCT0012117) titled 'An Exploratory Trial to Evaluate the Efficacy and Safety of the Signova Mobile App in Children and Adolescents with Tic Disorders' on June 12.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Single, Blinding Target : Investigator, Allocation : RCT
Primary Sponsor: Digitalmedic Co.
Condition:
Mental and behavioural disorders
Intervention:
Medical Device : Participants in the intervention group will maintain their usual care and additionally perform digital therapeutics-based training using a smartphone application at home for 6 weeks, ...